ALLO

Conviction 55HealthcareScan · Mon, Aug 10, 2026

ALLO$2.10+4.23%

ResistanceSupportVol 14Insider sell

Vol MA14 7.02M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Allogene Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.allogene.com ↗

Price2.10

Change+4.23%

Gap-1.00%

Rel volume2.30×

Avg volume6.44M

Avg $ vol12.03M

SMA 201.86

SMA 501.96

SMA 2001.89

Price vs 50+7.09%

Price vs 200+11.14%

MA stackbullish

50/200 cross—

Supertrendup · 1.71

RSI (14)60

MACD hist0.04

MACD crossbull · 7d

Stoch %K / %D99 / 96

ADX (14)17

+DI / −DI26 / 17

RSI divergence—

MACD divergenceBullish

ATR %+5.60%

ADR %5.95%

52w high3.06

52w low1.03

From 52w high-31.54%

Above 52w low+103.40%

New 52w highNo

SqueezeOff

Bollinger width21.65%

%B1.08

Donchian pos98.98%

Donchian high2.10

Donchian low1.61

AVWAP (52w high)2.25

vs AVWAP high-6.72%

AVWAP (52w low)2.02

vs AVWAP low+3.84%

OBV trendUp

Chaikin MF (20)0.08

Today vs 20d2.30×

Avg vol (14d)7.02M

Avg vol (20d)6.44M

Avg $ vol (20d)12.03M

Market cap723.1M

RS 3m (vs SPY)-17.15%

RS 6m (vs SPY)+9.20%

RS line new highNo

Trend template5/8

Technical rank79.5

1 week+13.86%

1 month+4.75%

3 months-8.11%

6 months+23.96%

1 year+99.52%

YTD+55.19%

P/E-3.79

P/B2.59

P/S—

P/FCF-4.83

EPS-0.8700

Div yield—

ROE-68.45%

ROA-48.21%

Debt/Eq—

Current9.65

EV/EBITDA-3.52

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth25.90%

Price target10.00

Target upside377.33%

Analyst ratingBuy

Institutional60.21%

Ent. value692.79M

Revenue0

Net income-42.61M

Gross profit—

Free cash flow-149.63M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out345.15M

Employees152

ListedThu, Oct 11, 2018

Free float169.95M

Float %69.4%

Short interest59.71M

Days to cover6.3d

Short volume55.6%

Squeeze score90 / 100

Next earningsWed, Aug 12, 2026 · after (2d)

EPS forecast−$0.16 · 4 est

Last EPS vs est−$0.18 vs −$0.19

Last surprise+5.3% beat

Setup gradeC

Conviction55 / 100

Pattern quality—

Tech rank79.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.22

Support1.68

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALLO

All disclosures →

No recent disclosed trades by Congress in ALLO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALLO · 2 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Roberts Zachary President and CEO · Restricted Stock Unit · 2026-07-01	Grant	134.53K	—	2026-07-01	2026-07-06
Roberts Zachary President and CEO · Stock Option (Right to buy) · 2026-07-01	Grant	476.19K	—	2026-07-01	2026-07-06
Yoshiyama Annie SVP, Finance · Common Stock · 2026-04-21	Sell	9.59K	$22K	2026-04-21	2026-04-23

SEC filings

EDGAR filings in ALLO · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.